InsiderTrades

Form 4 for REPL Replimune Group, Inc.

Accepted 2023-08-15 00:00:00 ET · period of report 2023-08-11 · accession 0001104659-23-092111 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-08-15 2023-08-11 REPL Esposito Pamela Chief Business Off M - OptEx $3.30 +1,400 264.8K +0.5% +$4,620
D 2023-08-15 2023-08-11 REPL Esposito Pamela Chief Business Off S - Sale+OE $20.00 -1,400 263.4K -0.5% -$28.0K
D 2023-08-15 2023-08-11 REPL Esposito Pamela Chief Business Off M - OptEx $0.00 -1,400 105.3K -1% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-11 M A 1,400 $3.30 264,836 D — —
2 Common Common Stock 2023-08-11 S D 1,400 $20.00 263,436 D — — (F2) Following the sales reported on this Form 4, the reporting person continues to beneficially own 263,436 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 515,827 shares of the Issuer's common stock, 397,473 of which are exercisable as of the date hereof.
3 Derivative Employee Stock Option (right to buy) 2023-08-11 M D 1,400 $0.00 105,291 D $3.30 · — to 2027-07-26 1,400 Common Stock (F3) The reporting person was granted an option to purchase 134,281 shares of the Issuer's common stock on July 26, 2017. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.